CXCR3

CXCR3 분자 정보

영어 이름C-X-C motif chemokine receptor 3시판 약물 수0
임상 약물 수2표적 별명CKR-L2,G protein-coupled receptor 9,IP-10 receptor,CXCR-3,CXC-R3,CXCR3,C-X-C Motif Chemokine Receptor 3,Interferon-Inducible Protein 10 Receptor,GPR9,C-X-C Chemokine Receptor Type 3,Chemokine Receptor 3,CD183 Antigen,CMKAR3,Chemokine (C-X-C Motif) Receptor 3,Mig Receptor,IP10-R,CD182,CD183,Mig-R,MigR,Receptors, CXCR3
최고 연구 개발 단계Phase 1 Clinical
영어 이름C-X-C motif chemokine receptor 3
표적 별명CKR-L2,G protein-coupled receptor 9,IP-10 receptor,CXCR-3,CXC-R3,CXCR3,C-X-C Motif Chemokine Receptor 3,Interferon-Inducible Protein 10 Receptor,GPR9,C-X-C Chemokine Receptor Type 3,Chemokine Receptor 3,CD183 Antigen,CMKAR3,Chemokine (C-X-C Motif) Receptor 3,Mig Receptor,IP10-R,CD182,CD183,Mig-R,MigR,Receptors, CXCR3
시판 약물 수0
임상 약물 수2
최고 연구 개발 단계Phase 1 Clinical

CXCR3 제품 목록

  • 속성

    Protein (4)Cell (2)

  • 제품 라이브러리

    온라인 (6)

  • Human (5)Mouse (1)

  • 태그

    - (5)His Tag & Flag Tag (1)

  • 마커

    Unconjugated (3)- (2)Biotin-labeled (1)

CXCR3분자 배경

Chemokines are proteins which induce chemotaxis, promote differentiation of immune cells, and cause tissue extravasation. Given these properties, their role in anti-tumor immune response in the cancer environment is of great interest. Although immunotherapy has shown clinical benefit for some cancer patients, other patients do not respond. One of the mechanisms of resistance to checkpoint inhibitors may be chemokine signaling. The CXCL9, -10, -11/CXCR3 axis regulates immune cell migration, differentiation, and activation, leading to tumor suppression (paracrine axis). However, there are some reports that show involvements of this axis in tumor growth and metastasis (autocrine axis). Thus, a better understanding of CXCL9, -10, -11/CXCR3 axis is necessary to develop effective cancer control.

CXCR3분자 별명

CD182, CD183, CKR-L2, CMKAR3, GPR9, IP10-R, Mig-R, MigR

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
OCU-110OCU-10-C-110; OGX-110; OCU-110Phase 1 ClinicalOcugenix CorpMacular Degeneration
상세
ACT-777991ACT-777991Phase 1 ClinicalIdorsia Pharmaceuticals LtdDiabetes Mellitus, Type 1; Inflammation
상세
  • 분자 정보
  • 제품 목록
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호